ABWN like I said before... they told investors that toxic

New Post Public Reply Private Reply Replies (1) Message Board
BionicBen
1,087
ABWN like I said before... they told investors that toxic financing was going to run this down to .25 aka -82.5% dilution... But now you have panic and it dropped to a penny. I think this will bounce back and hopefully we will hear something good about what was done with the money gained from the dilution.

FROM 6/5/18 POST:
https://investorshangout.com/post/view?id=5075074

This means the stock manipulation has been completed and we should be at bottom. GREAT find here. You can see that they were in talks and considering this option well in advanced of the filing date of 5/29/18. This is why and how the share price has dropped so much. Stock price was at $2.60 approx and they knew that the price was going to drop well below a dollar by may 2018, and basically expected it to hit the bottom at .25. Only the insiders knew the price was going to drop. Hopefully they are clean and did not profit from this. There is such thing as legal insider trading but it is between the executives and certain share holders and it usually never effects the common stock. This article however, is basically saying that once these preferred shares get converted the stock price will hit no lower than .25 (down 82.5%???) and IMO we are seeing it drop lower because anyone who does not understand this is now freaking out and just wants out because this could keep dropping to trips. I think .20 is close to the new floor. I expect news in the next 3-9 months to bring the price back up to around $1. jmho based off this letter and the chart.


https://finance.yahoo.com/news/airborne-wirel...rc=applewf
(...Each share of Preferred Stock is being sold together with (i) one Series 1 Warrant to purchase one share of Preferred Stock, (ii) one Series 2 Warrant to purchase one share of Preferred Stock, and (iii) one Series 3 Warrant to purchase one share of Preferred Stock. The Preferred Stock has an initial stated value of $1,150 and is convertible into shares of the Company's common stock at a conversion price equal to the lesser of (a) $0.71, subject to certain adjustments, or (b) 82.5% of the lowest volume weighted average price of the Company's Common Stock during the five trading days ending on, and including, the date of the notice of conversion. For the first 15 calendar days following the filing of the certificate of designations for the Preferred Stock, the conversion price is subject to a floor of $0.25 per share, except in the event of anti-dilution adjustments. Each Warrant will have an initial exercise price of $1,000 per share of Preferred Stock. The Series 1 Warrants, Series 2 Warrants and Series 3 Warrants will be immediately exercisable and will expire on the three-month, six-month, and twelve-month anniversary of the original issuance date, respectively...)

The Offering is expected to close on May 29, 2018, subject to the satisfaction of customary closing conditions.

https://www.investopedia.com/terms/i/insidertrading.asp
Illegal insider trading includes tipping others when you have any sort of nonpublic information. Legal insider trading happens when directors of the company purchase or sell shares, but they disclose their transactions legally.


Read More: https://investorshangout.com/post/view?id=507...z5IsvXejrN
Disclaimer:
There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator.
Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.
There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in all and any posts.
My posts are NOT investment advice. I am not paid to post.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 4

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 5

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading

Top 5 Most Recently Viewed Articles

Discovering Opportunities: North Dakota's Workforce Initiative

Updated Category News Views 172

Welcome to New Beginnings in North Dakota As the season of relocation kicks off, North Dakota is inviting jobseekers with its innovative campaign, Find the Good Life in North Dakota. This initiative coincides with National Moving Day, marking the start of a bustling season when many families seek new horizons across the country. Embrace New Opportunities "People are on...

Continue Reading
Caseware Innovations Garner Multiple Industry Accolades

Updated Category News Views 190

Celebrating Industry Recognition Caseware™, a pioneer in AI-enabled audit, financial reporting, and data analytics, has recently basked in a wave of industry accolades. These recognitions underscore the company's unmatched leadership in driving innovation and delivering impactful solutions to accounting professionals worldwide. A Double Triumph for Caseware In a...

Continue Reading
Telomir Pharmaceuticals' 31% Surge and Pre-market Movers

Updated Category News Views 181

Telomir Pharmaceuticals Sees Significant Pre-market Surge Shares of Telomir Pharmaceuticals Inc (NASDAQ: TELO) experienced a remarkable increase of 31%, reaching $1.86 in pre-market trading. This boost comes in the wake of encouraging preclinical results regarding their primary compound, Telomir-1. Promising Preclinical Study Results The biotechnology firm disclosed these...

Continue Reading
Tech Stocks Likely to Experience Significant Rebound Soon

Updated Category News Views 297

Market Overview for Potential Rebounds The stock market is often unpredictable, with certain stocks experiencing declines even after positive earnings reports. In recent times, some stocks have evidently fallen out of favor with investors, particularly following disappointing earnings or cautious guidance from companies. Interestingly, stocks with low expectations can...

Continue Reading
Acer Inc. Reports Impressive Q3 Performance with 36.1% Growth

Updated Category News Views 72

Acer Inc. Demonstrates Strong Quarter Over Quarter Growth Acer Inc. (TWSE: 2353) has recently shared impressive financial results for the third quarter of 2024, showcasing resilience and growth in a competitive market. The company reported consolidated revenues of NT$72.69 billion, reflecting an 8.3% increase compared to the previous quarter and a 7.8% rise year-on-year....

Continue Reading